InvestorsHub Logo
Followers 6
Posts 515
Boards Moderated 0
Alias Born 04/25/2010

Re: None

Thursday, 09/19/2019 7:21:14 PM

Thursday, September 19, 2019 7:21:14 PM

Post# of 424687
re: MRC...I'm wearing my tin-foil hat...

MRC has bothered me since they first appeared on the scene. Something is just not kosher with this firm.

First of all, their website originally claimed they needed to maintain their anonymity. Our own CalMustang exposes the character behind the curtain as Steve Giardino. Their website had to be updated to include his name as President and CEO. I believe this may have been necessary as somebody had to sign MRC's Citizen Petition submitted to the FDA.

Per CalMustang's research, the company was incorporated in New Mexico.
Company headquarters are a mail-drop in a non-descript building in St. Petersburg, FL.

It has been mentioned that Steve Giardino is based in Albany, NY.
There is another principal named James Murphy, that has the title of Marketing Director. His location is listed as Houston, TX.

Seems to be a lot of shenanigans to keep this firm on the 'down-low', yet they have garnered a lot of attention with their $32,000 analytical report and most recently their CP to the FDA bashing the AMRN Reduce-It results.

Just my opinion, but I believe a DS firm, or possibly the whole DS industry could be funding the initial report and the subsequent CP. If you check the MRC website, you will notice that no other bio-pharma firms are investigated. Either this Steve Giardino has an absolutely vicious vendetta against AMRN. or he and MRC have to have backing from other characters.

Attached is the response to MRC's FAQ regarding who is MRC...

Who are the people behind Medical Research Collaborative? *UPDATED*
Currently (as of June 20, 2019) there are two executive members of Medical Research Collaborative, LLC ("MRC"). Neither of these executive members have a medical degree, a PhD, a degree in regulatory science, or a law degree. MRC is a start-up company that is in a state of flux. At any given point in time, there may be multiple members (executive and non-executive) of MRC that have attained the aforementioned degrees, or there may be no members that have attained the aforementioned degrees. It is the intention of MRC to evolve into a research company that has a variety of experts that have earned the aforementioned, established degrees on its staff that serve as members involved in the research of healthcare companies.
The piece, entitled "Identification and Analysis of Amarin Corp.'s Harbingers of Bankruptcy," was wholly constructed by Steven Giardino, the President & CEO of MRC. This piece was professionally proof-read and also reviewed for accuracy/edit suggestions by multiple persons with science backgrounds, one of whom has an advanced medical degree. The final version was/is offered for sale on this website. Although Steven Giardino has self-proclaimed expertise in various pharmaceutical science topics, in regulatory science, and in patent law, he has not earned any of the aforementioned established degrees.
The goal of MRC is to make the research that we produce the focus; we do not believe knowledge of the writer(s) of a work is an appropriate lens through which to judge the work itself, and may bias the reader ("appeal to authority fallacy"). In our view, the work should stand or fall based on its own merits. Furthermore, the subject matter entailing our focus can at times be controversial, and the publication of reports on such result in the provocation of ad hominem attacks from investors in the companies we report on, distracting from the content of the work itself. Also, a truly zealous antagonist that misconstrues he has been harmed by our reports could in some instances jeopardize the careers of prospective/current members of MRC by harassing the establishments at which they are employed (not to mention their family members). For these reasons it is company policy that the identities of the members of MRC, except Steven Giardino, remain anonymous. If another member is named, that name is likely to be a pen name.

Could DS have funded the reports and petitions?? It is certainly plausible. Attached is huge report on omega-3s. It cites over 400 studies and papers.

Conflicts of interest
Financial support for this review was provided by DSM Nutritional Products and Norman Salem, Jr. is employed by DSM, a manufacturer of omega-3 fatty acids.

Here is the full PDF file containing the report and references to the 400+ papers & studies. It is a boatload of info.

https://www.sciencedirect.com/science/article/pii/S0163782715300333

DSM is huge company based in the Netherlands. They are involved in areas other than dietary supplements.

Could a firm such as this, or similar be funding MRC?? I don't know, but it isn't beyond the realm of possibilities.

I think I read in the past month or so that somebody mentioned on the iHub board that private investigators had been employed by AMRN and also a hedge fund to find out more particulars on MRC. I don't know if any of this is true. I certainly would like to find out who is pulling th strings behind MRC.

I have to go now, because the tin-foil in my nicely made hat is digging into my scalp.

Any Sherlock Holmes or Columbos out there?? Please chime in.

Cheers!
Flubber
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News